Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Editors Pick
    • Indian Scientist...

    Indian Scientist develops miracle vaccine for birth control

    Written by Medical Dialogues Bureau Published On 2018-04-17T20:30:29+05:30  |  Updated On 17 April 2018 8:30 PM IST
    Indian Scientist develops miracle vaccine for birth control

    Vaccines for control of fertility are likely to have an important impact on family planning methods.A number of birth control vaccines are at different stages of development, the most advanced being a vaccine inducing antibodies against human chorionic gonadotrophin (hCG).


    Dr G.P. Talwar, renowned professor and scientist and former director at National Institute of Immunology aged 91 has developed a miraculous vaccine which has now received approvals from Drug Controller General of India (DCGI) for Phase I clinical trial.It is the result of his hard work on a birth control vaccine for last 44 years.He had earlier developed the first leprosy vaccine in the world that was launched a few years back.


    The Indian Council of Medical Research (ICMR) has designed a protocol for this vaccine to be tested on 120 women at All India Institute of Medical Sciences (AIIMS) and Sir Ganga Ram Hospital (SGRH) in New Delhi.


    In the clinical trial, non-pregnant, but sexually active women, between 22 to 35 years, with two living children will be enrolled in the study according to protocol. In all 25 women will be enrolled at AIIMS and another 25 at SGRH. All the eligible candidates are being screened for recruitment in the Gynaecology departments at these hospitals and five doses — 100, 200, 300, 400 and 500 mg will be administered, respectively, to ten women.


    “If it passes through the human phases of clinical trials, it will be the world’s first birth control vaccine, which will temporarily protect women against pregnancy,” Dr Talwar told DNA.


    The contraceptives, at present have undesired side-effects like menstrual irregularity and breeding. The vaccine developed by Dr Talwar is claimed to overcome such undesirous side effects and is completely safe for the ovary.


    Speaking to Deccan Chronicle, Prof. Talwar said, “People thought I have gone weird when I planned to work on the birth control vaccine. The general perception is that vaccines should be developed only for infectious disease. However, that did not deter me from carrying this project. The vaccine would not only prevent pregnancy for over a year but also improve the cancer resistance power.”


    The vaccine prevents secretion of Beta Human Chorionic Gonadotrophin (HCG) hormone, which is crucial for implantation of the fertilized embryo to the uterus. If we can prevent this hormone from circulation in female’s blood, by generating antibodies through the vaccine, there will be no pregnancy,” said a senior scientist at ICMR


    This safe and effective contraceptive targets the human chorionic gonadotropin (hCG) hormone, which in turn produces hormone progesterone, which is necessary to prepare the uterus to receive the embryo. This vaccine blocks hCG and ensures termination of pregnancy,” he added


    The women will have a normal functioning sex life and menstrual cycle. She will have to take the vaccine once in close to three months for prevention of pregnancy, we pre-empt and she can simply discontinue it when she chooses to get pregnant,” said the scientist.


    The vaccine will overcome limitations of present-day contraceptives, which have undesired side-effects like menstrual irregularity and breeding. The vaccine would not harm the ovary anyway and if the vaccine successfully completes its clinical trial, it will be a new medical miracle by an Indian scientist.


    For further reference log on to : https://www.ncbi.nlm.nih.gov/pubmed/7683889
    birth controlbirth control vaccinebirth control vaccinescontraceptivesDr G.P. TalwarG P TalwarHCGhormonehuman chorionic gonadotropinIndian Council of Medical ResearchpreagnancySir Ganga Ram HospitalVaccinevaccines

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok